9.5-Year Follow-Up on Effects of Rituximab in RA Patients ProHealth The drug rituximab is used in combination with methotrexate to control autoimmune damage to RA patients' joints by reducing levels of a specific immune B-cell that attacks them. The therapy initially elevates risk of infection and malignancy somewhat. |
